What people report
BPC-157 reviews: what people report
Read 69 people, 4 sitesPublished by PepVault
Of the 69 people whose BPC-157 write-ups we read, 51 describe a change they wanted (26 less pain or faster healing; 12 less joint or tendon pain; 8 a calmer gut), 10 noticed nothing and 14 describe something unwanted.
What people report
51 of the 69 people describe at least one change they wanted. Each bar counts the people who named anything in that group, once each, out of all 69; the line under it says what they named, and how many named it. 22 of them took BPC-157 alongside other peptides at the same time.
What went wrong or did nothing
14 of the 69 people describe something they didn’t want, and 10 noticed nothing at all.
Your report
Taken BPC-157? What did you notice?
One tap to start. About 30 seconds, no account.

When people say it begins
22 of the 69 people say when they first noticed something; 47 don’t.
What people took it for
49 of the 69 people say what they took it for; 20 don’t.
How it’s thought to work
Shown in animals or cells
BPC-157 is a chain of fifteen amino acids taken from a protein found in human stomach juice. In rats it sped the healing of cut tendons, muscle and gut, and it grew new blood vessels into injured tissue; in rat tendon cells grown in a lab it helped the cells spread out and survive. How it would work in people has not been tested.
Sources: Staresinic et al., 2003: a cut Achilles tendon in rats; Chang et al., 2011: rat tendon cells grown in a lab; Hsieh et al., 2017: new blood vessels and blood flow in rats; McGuire et al., 2025: a review of the evidence, University of Utah
What studies show
Our research section has 14 study pages on BPC-157: 10 in rats, 2 in people, 1 in mice and 1 in lab-grown cells.
The largest study in people looked back at the records of 16 people given BPC-157 injections for knee pain, and 14 of them said the pain eased; there was no comparison group.
No controlled study in people has tested BPC-157.
- BPC-157: 10 of 12 women reported full interstitial cystitis relief
- BPC-157: 14 of 16 reported knee pain relief in a chart review
- BPC-157: non-significant tendon gains in rats; TB-500 did better
- BPC-157 reduced leg muscle damage after ischemia-reperfusion in rats
- BPC-157 closed duodenocolic fistulas in rats
- BPC-157 limited isoprenaline-induced heart attack damage in rats
- BPC-157 reduced radiation liver injury in mice and rat liver cells
- BPC-157 restored cut muscle-tendon junctions in rats
- BPC-157 aided recovery after hippocampal blood-flow injury in rats
- BPC-157 sped blood flow recovery in rats with hind limb ischemia
- BPC-157 countered succinylcholine hyperkalemia and arrhythmias in rats
- BPC-157 sped alkali burn wound closure in rats
- BPC-157 sped Achilles tendon healing in rats
- BPC-157 sped tendon cell outgrowth and migration in rat cells
- BPC-157 in the library: how it works, half-life and evidence
- Is BPC-157 legal? FDA, DEA and WADA status
- BPC-157 dose guide
Where the reports run ahead of the studies
31 of the 69 people describe less pain or faster healing after an injury or in sore joints. Only three small pilot studies have tested BPC-157 in people (knee pain, a bladder condition and a safety test), none with a comparison group and none in tendons or the gut (PubMed, searched November 19, 2026).
Where the reports come from
69 people on 34 pages across 4 sites, written from January 2017 to November 2026. Read on November 19, 2026.
The largest single site, LongeCity, gave 23 of the 69 (33%).
Peptide Critic, which runs its forum, also runs a shop on its own site that sells injection pens and supplies, not peptides.
- LongeCity forum, the “BPC-157” thread: 17 people
- rapamycin.news forum, the peptides and bioregulators thread: 14 people
- LongeCity forum, a thread on BPC-157 and brain chemistry: 6 people
- Peptide Critic forum, a thread on capsules: 2 people
- Peptide Critic forum, a shoulder-healing thread: 1 person
- Peptide Critic forum, a thread on injecting into muscle: 1 person
- Peptide Critic forum, a wound-healing thread: 1 person
- Peptide Critic forum, a red-light thread: 1 person
- Peptide Critic forum, a BPC-157 and TB-500 thread: 1 person
- Peptide Critic forum, a thread on how people started: 1 person
- Peptide Critic forum, a thread on a knee injury: 1 person
- Peptide Critic forum, a thread on peptides that surprised people: 1 person
- Peptide Critic forum, a BPC-157 or Wolverine thread: 1 person
- Peptide Critic forum, a BPC-157 tiredness thread: 1 person
- Peptide Critic forum, a KPV thread: 1 person
- X, public posts: 19 people (post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post)
Read and not counted
- A Peptide Critic forum staff member’s posts: The same account posts the forum’s vendor sales roundups, and the site runs its own store: the seller’s side of the counter, so not counted.
- Reviews of shops on the Peptide Critic forum: Written about a seller rather than the peptide; an advertisement, so not counted.
- A rapamycin.news member who supplies peptides to clients: Writes of clients who get peptides from them: the seller’s side of the counter, so not counted.
- A clinician on rapamycin.news who gives it to patients: A report on patients, from the person who supplies it, not a person’s own.
- Reports about someone else (a friend’s father, a colleague, a partner, pets): Second-hand; only a person’s own report counts.
- A summary of Reddit comments shared on the Peptide Critic forum: Built from Reddit, which this count does not read.
- Blends taken with no word on BPC-157 itself (KLOW, GLOW and the like): Counted only where the person names BPC-157 among what they took.
- The organiser of a LongeCity group buy: The member who started the thread arranged a group order for other members: closer to the counter than the reader, so not counted.
- A capsule blend sold with other joint ingredients: A LongeCity member praised a product that mixes BPC-157 with other ingredients and said nothing of BPC-157 itself.
- Posts on X from sellers, about someone else, or with no outcome: An account promoting a tablet, a coach, a clinic, a poster speaking for clients, vendors, posts about a dog or family members, stacks where the effect could not be put on BPC-157, explainers and podcast retellings, and questions or plans with nothing noticed; not counted.
- Reddit: Not part of this count.
How we counted
We read every open write-up we could find by people who took BPC-157, on its own page, and counted each person once however often they posted, including those who noticed nothing. Sellers, clinics, shop reviews and anyone who earns on a sale are not counted, and neither is a search result’s snippet; the list above names what we read and left out. Write-ups lean positive, because people who notice nothing rarely write about it and expecting an effect can produce one. People on X and on the forums can’t be matched to each other, so someone who wrote in both places may be counted twice.
Spot an error? feedback@pepvault.app. How we research. This page reports what people say; it is not medical advice.